A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 yearsMeta-Analysis Published on 2022-07-012023-06-01 Journal: Modern rheumatology [Category] 두창, 수두, 홍역, [키워드] herpes zoster Janus kinase inhibitor Peficitinib rheumatoid arthritis serious infection. [DOI] 10.1093/mr/roab069 PMC 바로가기 [Article Type] Meta-Analysis
Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritisClinical Trial Published on 2022-07-012023-06-01 Journal: Modern rheumatology [Category] 두창, 수두, 홍역, [키워드] elderly Janus kinase inhibitor Peficitinib renal impairment rheumatoid arthritis. [DOI] 10.1093/mr/roab058 PMC 바로가기 [Article Type] Clinical Trial
Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and TaiwanResearch Article Published on 2020-03-122023-05-22 Journal: Arthritis Research & Therapy [Category] Fulltext, 수두, 홍역, [키워드] ASP015K Janus kinase Long-term extension study Peficitinib rheumatoid arthritis [DOI] 10.1186/s13075-020-2125-2 PMC 바로가기 [Article Type] Research Article